Edgewise Therapeutics, Inc., (EWTX), a biopharmaceutical company, Monday announced that it has appointed Michael Nofi as its new chief financial officer, effective November 10.
Nofi succeeds Michael Carruthers who is retiring.
Michael Nofi has over 30 years of leadership experience in finance and accounting across public and private companies primarily in the life sciences sector and joins the company after serving as the chief accounting officer at SpringWorks Therapeutics, Inc.
In pre-market activity, EWTX shares were trading at $17.60, up 2.56% on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.